The California stem cell agency has posted on the Internet additional background material on its proposed $500 million biotech loan program, but other key information to be considered by the agency's directors during their meeting this afternoon and tomorrow is still not yet available to the public.
Only cryptic phrases, with no explanation or links, can be found on the CIRM Oversight Committee agenda on the following subjects:
-- A proposal for fast-tracking "urgent" or "opportune" research opportunities
-- Changes in the rules for running the agency's $262 million stem cell lab grant program
-- A definition of California "supplier," which could help to ensure that California firms get preference in tens of millions of dollars linked to CIRM spending
-- Equipment funding for the stem cell lab construction program
-- And recommendations that would define "principal investigator" and his/her responsibilities in connection with CIRM research.
The Oversight Committee is scheduled to meet at 4:30 p.m. today in Los Angeles.
No comments:
Post a Comment